The number of new cases of pheochromocytoma is estimated to be two to eight cases per million people per year,1 although the actual prevalence may be higher.2 For malignant pheochromocytoma, the incidence was 93 cases per 400 million people in the United States in 2002.3
- Timmers, H. J., Gimenez-Roqueplo, A. P., Mannelli, M., & Pacak, K. (2009).Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocrine-Related Cancer 16: 391-400. [top]
- Pacak, K., Eisenhofer, G., Ahlman, H., Bornstein, S. R., Gimenez-Roqueplo, A. P., Grossman, A. B., et al. (2007). Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005. Nature Clinical Practice Endocrinology & Metabolism 3: 92-102. [top]
- Grogan, R. H., Mitmaker, E. J., & Duh, Q. Y. (2011). Changing paradigms in the treatment of malignant pheochromocytoma. Cancer Control 18: 104-112.[top]